This study is currently recruiting participants.
Number
12-EI-0042
Sponsoring Institute
National Eye Institute (NEI)
Recruitment Detail
Type: Participants currently recruited/enrolled Gender: Male & Female Min Age: 2 Years Max Age: 120 Years
Referral Letter Required
No
Population Exclusion(s)
None
Keywords
Biological Specimens; Retinal Disease; Diabetic Retinopathy; Phenotype-Genotype correlation; Age-Related Macular Degeneration (AMD); Natural History
Recruitment Keyword(s)
Retinal Disease; Age-Related Macular Degeneration (AMD); AMD; Diabetic Retinopathy; Healthy Volunteer; HV
Condition(s)
Age-Related Macular Degeneration; Diabetic Retinopathy; Von Hippel-Lindau Syndrome; Retinal Disease; Retinal Vein Occlusion
Investigational Drug(s)
Investigational Device(s)
Intervention(s)
Supporting Site
National Eye Institute
- To understand diseases of the retina and the eye, information is needed about people with and without such diseases. Researchers want to study these people and follow them over time. They also want to study body tissues and blood to understand the nature of eye disease. Studying genes, cells, and tissues may help them understand why some people get eye problems and others do not, or why some people respond to treatment while others do not. Researchers want to collect physical samples and personal data to develop a National Eye Institute database.
Objectives:
- To collect health information and blood and tissue samples from people with and without eye diseases, to be used in research studies.
Eligibility:
- Individuals at least 2 years of age with different types of eye disease.
- Healthy volunteers with no history of eye disease.
Design:
- Participants may be recruited from National Eye Institute studies or may be referred from other sources.
- Participants will be screened with a physical exam and medical history. They will also have a full eye exam. Questions will be asked about family medical history, especially about eye disease.
- Blood samples will be collected. Other samples, such as saliva, tears, hair, stool, and urine, may be collected as needed. Adult participants may also provide a skin sample.
- Tissue or fluid from eye collected as part of eye care or treatment may also be added to the database.
- No treatment will be provided as part of this study.
--Back to Top--
INCLUSION CRITERIA: Participants will be eligible if they: -Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children. -Manifest diagnosed or undiagnosed retinal disease(s), or could serve as an unaffected control suitable for comparison to participants with various retinal diseases, particularly AMD and diabetic retinopathy (taking into account matching factors such as age and past ocular history). EXCLUSION CRITERIA: Participants will not be eligible if they: -Are unable or unwilling to give informed consent that includes collection and study of at least one peripheral blood sample. -Are unable or unwilling to give informed consent that includes use of NIH medical records and clinical samples for research. -Have a systemic disease that compromises the ability to provide adequate ophthalmologic examination or treatment.
Participants will be eligible if they:
-Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children.
-Manifest diagnosed or undiagnosed retinal disease(s), or could serve as an unaffected control suitable for comparison to participants with various retinal diseases, particularly AMD and diabetic retinopathy (taking into account matching factors such as age and past ocular history).
EXCLUSION CRITERIA:
Participants will not be eligible if they:
-Are unable or unwilling to give informed consent that includes collection and study of at least one peripheral blood sample.
-Are unable or unwilling to give informed consent that includes use of NIH medical records and clinical samples for research.
-Have a systemic disease that compromises the ability to provide adequate ophthalmologic examination or treatment.
Principal Investigator
Referral Contact
For more information: